Pre-operative chemoradiation for non-metastatic locally advanced rectal cancer.

PubWeight™: 1.09‹?› | Rank: Top 10%

🔗 View Article (PMID 23235660)

Published in Cochrane Database Syst Rev on December 12, 2012

Authors

Kathryn McCarthy1, Katherine Pearson, Rachel Fulton, Jonathan Hewitt

Author Affiliations

1: Frenchay Hospital, Bristol, UK. 2Dorset County Hospital, Dorchester, UK. kathrynmccarthy@doctors.org.uk.

Articles citing this

Overview of radiation therapy for treating rectal cancer. Ann Coloproctol (2014) 0.86

Patterns of Colorectal Cancer Care in the United States: 1990-2010. J Natl Cancer Inst (2015) 0.85

Restaging after neoadjuvant chemoradiation in rectal cancers: is histology the key in patient selection? J Gastrointest Oncol (2016) 0.83

Effect of chemoradiotherapy and neoadjuvant chemoradiotherapy in resectable pancreatic cancer: a systematic review and meta-analysis. J Cancer Res Clin Oncol (2013) 0.82

The prognostic impact of preoperative blood monocyte count in pathological T3N0M0 rectal cancer without neoadjuvant chemoradiotherapy. Tumour Biol (2015) 0.81

Sphincter-sparing surgery in patients with low-lying rectal cancer: techniques, oncologic outcomes, and functional results. J Gastrointest Surg (2014) 0.79

Early increase in circulating carbonic anhydrase IX during neoadjuvant treatment predicts favourable outcome in locally advanced rectal cancer. BMC Cancer (2015) 0.78

2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications. Oncotarget (2017) 0.77

Gastrointestinal cancers in India: Treatment perspective. South Asian J Cancer (2016) 0.77

Surgeon perspectives on the use and effects of neoadjuvant chemoradiation in the treatment of rectal cancer: a comprehensive review of the literature. Langenbecks Arch Surg (2015) 0.77

Rate of pulmonary metastasis varies with location of rectal cancer in the patients undergoing curative resection. World J Surg (2015) 0.77

Pelvic radiotherapy and sexual function in women. Transl Androl Urol (2015) 0.76

Consensus statement: the 16th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan; September 5-6, 2014. Curr Oncol (2015) 0.75

Radiotherapy for Colorectal Cancer: Current Standards and Future Perspectives. Visc Med (2016) 0.75

Adjuvant versus neoadjuvant chemoradiotherapy in distal rectal cancer: Comparison of two decades in a single center. Ulus Cerrahi Derg (2015) 0.75

Tailored Treatment of Colorectal Cancer: Surgical, Molecular, and Genetic Considerations. Clin Med Insights Oncol (2017) 0.75

The effects of neoadjuvant chemoradiotherapy and an in-hospital exercise training programme on physical fitness and quality of life in locally advanced rectal cancer patients (The EMPOWER Trial): study protocol for a randomised controlled trial. Trials (2016) 0.75

Adjuvant chemotherapy for rectal cancer: Is it needed? World J Clin Oncol (2015) 0.75

Is Preoperative Chemoradiotherapy Beneficial for Sphincter Preservation in Low-Lying Rectal Cancer Patients? Medicine (Baltimore) (2016) 0.75

Annual hazard rate of relapse of stage II and III colorectal cancer after primary therapy. Clin Transl Oncol (2017) 0.75

Neoadjuvant chemoradiation with concomitant boost radiotherapy associated to capecitabine in rectal cancer patients. Int J Colorectal Dis (2014) 0.75